LUPIA, Antonio
 Distribuzione geografica
Continente #
EU - Europa 16.569
AS - Asia 671
NA - Nord America 531
SA - Sud America 118
AF - Africa 25
OC - Oceania 2
Totale 17.916
Nazione #
IT - Italia 16.354
US - Stati Uniti d'America 512
SG - Singapore 305
CN - Cina 223
BR - Brasile 93
DE - Germania 60
VN - Vietnam 45
HK - Hong Kong 28
FR - Francia 26
NL - Olanda 26
KR - Corea 23
FI - Finlandia 21
AT - Austria 19
GB - Regno Unito 18
IN - India 13
SE - Svezia 13
AR - Argentina 11
MX - Messico 11
BD - Bangladesh 8
IE - Irlanda 8
MA - Marocco 8
IQ - Iraq 6
ZA - Sudafrica 6
CA - Canada 5
ES - Italia 5
RU - Federazione Russa 5
EC - Ecuador 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
JP - Giappone 3
PY - Paraguay 3
TN - Tunisia 3
BE - Belgio 2
EG - Egitto 2
HN - Honduras 2
ID - Indonesia 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
UZ - Uzbekistan 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
UG - Uganda 1
Totale 17.916
Città #
Cagliari 14.593
Uta 1.607
Singapore 175
Ashburn 95
Dallas 89
Boardman 84
Hefei 59
Beijing 42
Santa Clara 36
Los Angeles 29
Hong Kong 27
Ho Chi Minh City 23
Seoul 23
Milan 16
Munich 16
The Dalles 14
Naples 13
Vienna 13
Frankfurt am Main 12
Redondo Beach 12
Buffalo 11
Hanoi 11
Helsinki 11
Nuremberg 10
Sassari 9
Selargius 9
São Paulo 9
Dublin 8
Washington 8
Amsterdam 7
Lappeenranta 7
Casablanca 6
New York 6
Stockholm 6
Johannesburg 5
Krefeld 5
Shanghai 5
Baghdad 4
Brooklyn 4
Düsseldorf 4
Hoorn 4
London 4
Manchester 4
Perugia 4
Phoenix 4
Rome 4
Atlanta 3
Biên Hòa 3
Boston 3
Buenos Aires 3
Campos dos Goytacazes 3
Chennai 3
Columbus 3
Dubai 3
Islington 3
Lauterbourg 3
Mexico City 3
Montesilvano Marina 3
Orem 3
Rosignano Marittimo 3
Roubaix 3
Salt Lake City 3
San Francisco 3
Turin 3
Turku 3
Warsaw 3
Bad Durrheim 2
Bari 2
Belo Horizonte 2
Bishkek 2
Bologna 2
Chicago 2
Contagem 2
Curitiba 2
Dalian 2
Denver 2
Dhaka 2
Feira de Santana 2
Gaeta 2
Hamburg 2
Leuven 2
Manfredonia 2
Monza 2
Moscow 2
New Delhi 2
Newark 2
Orotelli 2
Osasco 2
Parma 2
Pescara 2
Posadas 2
Querétaro 2
Quito 2
Riga 2
San Pedro Sula 2
Tashkent 2
Tokyo 2
Toronto 2
Tunis 2
Turate 2
Totale 17.275
Nome #
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 1.207
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 1.072
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 952
Is there a role for dual PI3K/mTOR inhibitors for patients affected with lymphoma? 858
Current updates on naturally occurring compounds recognizing sars-cov-2 druggable targets 853
In silico food-drug interaction: A case study of eluxadoline and fatty meal 786
Inside perspective of the synthetic and computational toolbox of JAK inhibitors: Recent updates 768
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 766
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 765
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators 717
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders 703
Computer-based techniques for lead identification and optimization II: Advanced search methods 671
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 661
Peptide platform as a powerful tool in the fight against covid-19 655
Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 639
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 617
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 566
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 553
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 551
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 515
Computer-based techniques for lead identification and optimization i: Basics 484
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 393
Identification of Compounds Targeting HuD. Another Brick in the Wall of Neurodegenerative Disease Treatment 375
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 293
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 263
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 244
Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors 234
New Structural Features of Isatin Dihydrothiazole Hybrids for Selective Carbonic Anhydrase Inhibitors 232
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B 217
A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancers 160
Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases 103
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 83
3D variability analysis reveals a hidden conformational change controlling ammonia transport in human asparagine synthetase 74
Totale 18.030
Categoria #
all - tutte 25.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234.313 0 0 0 0 0 13 5 0 31 53 73 4.138
2023/20245.499 1.027 131 156 311 374 756 717 524 221 387 524 371
2024/20257.091 927 1.314 1.389 1.110 496 785 632 59 91 86 81 121
2025/20261.127 259 140 213 178 175 162 0 0 0 0 0 0
Totale 18.030